
    
      70 subjects will be enrolled in this study in 3 study groups: A) 30 subjects with light chain
      cardiac amyloidosis B) 30 subjects with transthyretin cardiac amyloidosis and C) 10 subjects
      without amyloidosis. All subjects will undergo rest 2D echocardiography, rest N-13 ammonia
      perfusion PET, Definity infusion with high mechanical index (MI) imaging defined as
      sonotherapy in this study protocol.
    
  